Zegalogue

Clinical

Trials by Indication[1]

Type 1 Diabetes4 trials

Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents

Completed·Novo Nordisk·Phase 1·NCT06588504·38 enrolled

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects

Completed·Zealand Pharma·Phase 3·NCT03378635·170 enrolled

Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes

Completed·SSteno Diabetes Center Copenhagen·Phase 2·NCT04449692·20 enrolled

Show 1 more trial

Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes

Completed·SSteno Diabetes Center Copenhagen·Phase 2·NCT04764968·24 enrolled

Hypoglycemia4 trials

Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children

Completed·Zealand Pharma·Phase 3·NCT03667053·42 enrolled

Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM

Completed·Zealand Pharma·Phase 3·NCT03688711·45 enrolled

Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults

Withdrawn·Zealand Pharma·Phase 2·NCT04824872

Show 1 more trial

A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D

Completed·Zealand Pharma·Phase 3·NCT05378672·8 enrolled

Hyperinsulinism2 trials

A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism

Completed·Zealand Pharma·Phase 3·NCT03777176·32 enrolled

Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism

Completed·Zealand Pharma·Phase 2/3·NCT04172441·12 enrolled

Type 1 Diabetes Mellitus1 trial

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

Completed·Zealand Pharma·Phase 3·NCT03216226·112 enrolled

Treatment1 trial

Treatment of Post-bariatric Hypoglycaemia

Completed·FFilip Krag Knop·Phase 2·NCT04836273·24 enrolled

4 more indications

MPA1 trial

Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration

Completed·Zealand Pharma·Phase 1·NCT03735225·60 enrolled

Efficacy and Safety1 trial

A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM

Completed·Zealand Pharma·Phase 3·NCT03895697·92 enrolled

Congenital Hyperinsulinism1 trial

An Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon for the Treatment of Children With Congenital Hyperinsulinism

Completed·Zealand Pharma·Phase 3·NCT03941236·42 enrolled

Unspecified2 trials

A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System

Withdrawn·IInreda Diabetic B.V.·Phase 2·NCT05454709

The Bihormonal iLet Bionic Pancreas Feasibility Study

Completed·MMassachusetts General Hospital·Phase 2/3·NCT03840278·12 enrolled

Regulatory

FDA Approval Timeline[3]

Details

Drug Info

Patent Landscape[4]

Related News